Study | Year | Country | Number of patients | Number of knees | CR/PS | Brand of prosthesis (SR: MR) | SR | MR | Gender (M/F) | Average age (y) | Mean follow-up (mo) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SR | MR | SR | MR | ||||||||||
Hall [14] | 2008 | USA | 100 | 100 | CR | Scorpio: PFC | 50 | 50 | n/s | n/s | 69.5 | 72.6 | 12 |
Molt [24] | 2012 | Sweden | 60 | 60 | CR | Triathlon: Duracon | 30 | 30 | 8/22 | 13/17 | 69 | 66 | 24 |
Jo [21] | 2014 | South Korea | 100 | 100 | CR | Scorpio: NexGen | 50 | 50 | 6/44 | 9/41 | 66.4 | 67.5 | 36.8 |
Hamilton [20] | 2015 | UK | 212 | 212 | CR | Triathlon: Kinemax | 108 | 104 | 46/62 | 35/69 | 69.3 | 68.8 | 36 |
Kim [22] | 2015 | South Korea | 120 | 120 | PS | Triathlon: PFC Sigma | 60 | 60 | n/s | n/s | 67.2 | 67.2 | 12 |
Larsen [23] | 2015 | USA | 32 | 32 | PS | Triathlon: Vanguard | 16 | 16 | 8/8 | 8/8 | 71.6 | 70.9 | 12 |
Collados-Maestre [19] | 2017 | Spain | 237 | 237 | CR | Trekking: Multigen | 118 | 119 | 37/81 | 35/84 | 71.9 | 10.6 | 68.4 |
Wellman [26] | 2017 | USA | 40 | 40 | CR | Triathlon: NexGen | 20 | 20 | 8/12 | 10/10 | 61.9 | 63.1 | 12 |
Mushtaq [25] | 2018 | UK | 105 | 105 | PS | Scorpio: AGC | 51 | 54 | n/s | n/s | n/s | n/s | 12 |